Phospholipase Cγ2 contributes to light-chain gene activation and receptor editing

被引:19
作者
Bai, Li
Chen, Yuhong
He, Yinghong
Dai, Xuezhi
Lin, Xueyan
Wen, Renren
Wang, Demin
机构
[1] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA
[2] Dali Univ, Dalian 671000, Yunnan, Peoples R China
[3] Sun Yat Sen Univ, Sch Preclin Med, Guangzhou 510080, Guangdong, Peoples R China
[4] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
[5] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
关键词
D O I
10.1128/MCB.02273-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phospholipase C gamma 2 (PLC gamma 2) is critical for pre-B-cell receptor (pre-BCR) and BCR signaling. Current studies discovered that PLC gamma 2-deficient mice had reduced immunoglobulin lambda (Ig lambda) light-chain usage throughout B-cell maturation stages, including transitional type 1 (T1), transitional type 2 (T2), and mature follicular B cells. The reduction of Ig lambda rearrangement by PLC gamma 2 deficiency was not due to specifically increased apoptosis or decreased proliferation of mutant Ig lambda(+) B cells, as lack of PLC gamma 2 exerted a similar effect on apoptosis and proliferation of both Ig lambda(+) and Ig kappa(+) B cells. Moreover, PLC gamma 2-deficient Ig(HEL) transgenic B cells exhibited an impairment of antigen-induced receptor editing among both the endogenous lambda and kappa loci in vitro and in vivo. Importantly, PLC gamma 2 deficiency impaired BCR-induced expression of IRF-4 and IRF-8, the two transcription factors critical for lambda and kappa light-chain rearrangements. Taken together, these data demonstrate that the PLC gamma 2 signaling pathway plays a role in activation of light-chain loci and contributes to receptor editing.
引用
收藏
页码:5957 / 5967
页数:11
相关论文
共 73 条
[1]   DEVELOPMENT OF THE PRIMARY ANTIBODY REPERTOIRE [J].
ALT, FW ;
BLACKWELL, TK ;
YANCOPOULOS, GD .
SCIENCE, 1987, 238 (4830) :1079-1087
[2]   Re-evaluation of the probabilities for productive rearrangements on the kappa and lambda loci [J].
Arakawa, H ;
Shimizu, T ;
Takeda, S .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (01) :91-99
[3]   The mechanism and regulation of chromosomal V(D)J recombination [J].
Bassing, CH ;
Swat, W ;
Alt, FW .
CELL, 2002, 109 :S45-S55
[4]   Assembly requirements of PU.1-Pip (IRF-4) activator complexes:: inhibiting function in vivo using fused dimers [J].
Brass, AL ;
Zhu, AQ ;
Singh, H .
EMBO JOURNAL, 1999, 18 (04) :977-991
[5]   Contribution of receptor editing to the antibody repertoire [J].
Casellas, R ;
Shih, TAY ;
Kleinewietfeld, M ;
Rakonjac, J ;
Nemazee, D ;
Rajewsky, K ;
Nussenzweig, MC .
SCIENCE, 2001, 291 (5508) :1541-1544
[6]   Bruton's tyrosine kinase regulates the activation of gene rearrangements at the λ light chain locus in precursor B cells in the mouse [J].
Dingjan, GM ;
Middendorp, S ;
Dahlenborg, K ;
Maas, A ;
Grosveld, F ;
Hendriks, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (10) :1169-1178
[7]   Receptor editing in positive and negative selection of B lymphopoiesis [J].
Edry, E ;
Melamed, D .
JOURNAL OF IMMUNOLOGY, 2004, 173 (07) :4265-4271
[8]   ANALYSIS OF IMMUNOGLOBULIN GENE REARRANGEMENTS IN SINGLE B-CELLS [J].
EHLICH, A ;
KUPPERS, R .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (02) :281-284
[9]   PIP, A NOVEL IRF FAMILY MEMBER, IS A LYMPHOID-SPECIFIC, PU.1-DEPENDENT TRANSCRIPTIONAL ACTIVATOR [J].
EISENBEIS, CF ;
SINGH, H ;
STORB, U .
GENES & DEVELOPMENT, 1995, 9 (11) :1377-1387
[10]  
Engel H, 1999, EUR J IMMUNOL, V29, P2167, DOI 10.1002/(SICI)1521-4141(199907)29:07<2167::AID-IMMU2167>3.0.CO